We are pleased to inform you that the first trial participant was enrolled at the University Medical Center in Leiden on 10th of September 2021. Thank you for your great effort!
We are happy to inform you that the second patient was enrolled in the University Hospital of Geneva. Thank you for your excellent work!
We are happy to inform you that the first site, the Leiden University Medical Center (LUMC), in the Netherlands is open for accrual since July 7 2021. We wish the study team in Leiden good luck!
We are happy to inform you that the first patient was enrolled in the Hospital of Delémont. Thank you for your effort in enrolling patients!
On March 25, 2021 the 20th patients was enrolled into SAFE-SSPE trial. Thank you all for your effort in screening and recruiting patients!
We are happy to inform you that the first patient was enrolled in the Cantonal Hospital of Frauenfeld. Thank you for your effort in enrolling patients!
We are happy to inform you that Dr. Mallory Moret Bochatay has taken over the PI responsibility from Prof. T. Fumeaux at the Hospital of Nyon. Welcome to the SAFE-SSPE trial!
We are happy to inform you that the Hospital of Delémont is now open for patient accrual. All planned 23 Swiss sites are now initiated and open for accrual. We wish the study team in Delémont good luck!
We are happy to inform you that the first study participant was enrolled at the Triemli Hospital in Zurich today. We would like to thank the study team for the good collaboration
Prof. Dr. med. Drahomir Aujesky
Klinikdirektor und Chefarzt Allgemeine Innere Medizin
Universitätsspital Inselspital
safe-sspe@insel.ch